California's biotechnology sector is experiencing substantial workforce reductions, with over 1,000 employees affected year-to-date. Nine companies have eliminated at least half of their staff, and two have completely shut down operations. These layoffs span both smaller startups and larger pharmaceutical firms. The trend of significant job cuts has accelerated as the year progressed, with many announced in the final quarter. This widespread reduction highlights challenges within the biopharma industry.
California
https://www.biospace.com/job-trends/9-biotechs-will-cut-at-least-half-their-california-workforces